Rami Katkhuda
Stock Analyst at LifeSci Capital
(4.87)
# 324
Out of 4,339 analysts
293
Total ratings
52.2%
Success rate
30.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rami Katkhuda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $33 | $18.23 | +81.02% | 39 | May 19, 2026 | |
| ELDN Eledon Pharmaceuticals | Rated: Buy | $4 → $6 | $3.89 | +54.24% | 38 | May 16, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintained: Buy | $24 | $13.68 | +75.44% | 13 | May 16, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $57 | $26.35 | +116.32% | 6 | May 16, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $35 | $17.00 | +105.88% | 46 | May 9, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | $125 | $86.82 | +43.98% | 22 | May 9, 2026 | |
| IRON Disc Medicine | Maintained: Buy | $100 | $68.12 | +46.80% | 35 | May 9, 2026 | |
| VERA Vera Therapeutics | Rated: Buy | $90 | $34.34 | +162.09% | 35 | May 9, 2026 | |
| JBIO Jade Biosciences | Rated: Buy | $24 | $21.71 | +10.55% | 2 | May 9, 2026 | |
| MLYS Mineralys Therapeutics | Rated: Buy | $54 | $29.99 | +80.06% | 23 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $5.16 | +171.32% | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.6795 | - | 22 | Aug 14, 2025 |
MoonLake Immunotherapeutics
May 19, 2026
Maintained: Buy
Price Target: $33
Current: $18.23
Upside: +81.02%
Eledon Pharmaceuticals
May 16, 2026
Rated: Buy
Price Target: $4 → $6
Current: $3.89
Upside: +54.24%
Amylyx Pharmaceuticals
May 16, 2026
Maintained: Buy
Price Target: $24
Current: $13.68
Upside: +75.44%
Maze Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $57
Current: $26.35
Upside: +116.32%
Viridian Therapeutics
May 9, 2026
Maintained: Buy
Price Target: $35
Current: $17.00
Upside: +105.88%
Dianthus Therapeutics
May 9, 2026
Maintained: Buy
Price Target: $125
Current: $86.82
Upside: +43.98%
Disc Medicine
May 9, 2026
Maintained: Buy
Price Target: $100
Current: $68.12
Upside: +46.80%
Vera Therapeutics
May 9, 2026
Rated: Buy
Price Target: $90
Current: $34.34
Upside: +162.09%
Jade Biosciences
May 9, 2026
Rated: Buy
Price Target: $24
Current: $21.71
Upside: +10.55%
Mineralys Therapeutics
May 9, 2026
Rated: Buy
Price Target: $54
Current: $29.99
Upside: +80.06%
Mar 31, 2026
Maintained: Buy
Price Target: $14
Current: $5.16
Upside: +171.32%
Aug 14, 2025
Maintained: Hold
Price Target: n/a
Current: $0.6795
Upside: -